Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...

However tough some of the recent seasons have been, Wolves are still a top-flight club. For much of the 30 years before Fosun ...

Fosun Pharmaceutical Group has agreed to sell its entire stake in United Family Healthcare to Calcite Gem Investments Group ...

Being in a position of relative safety means the club can now plan early for next season, but will they make the most of it?

Brian asked: Why are Fosun holding on to the club and risking relegation every season? Would they consider appointing an experienced director of football to allow Jeff Shi to run the business side?

Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...

Last week saw Wolves publish their accounts for the 2023/24 financial year, with the headline figures being that the club ...

Fintel reports that on March 24, 2025, Lake Street initiated coverage of Hyperfine (NasdaqGM:HYPR) with a Buy recommendation.

SHANGHAI -- Chinese drugmaker Fosun Pharmaceutical Group has agreed to sell its stake in a hospital group to U.S. private equity firm Warburg Pincus for $124.08 million.

Real estate brokers are hopeful that the new Printemps store at One Wall Street will have a spillover effect on retail ...

Xi Jinping posed for a selfie with Sergio Aguero and David Cameron, but are China still on track to meet his footballing ...